HUL unlikely to become the largest food company: Experts
NEW DELHI: Hindustan Unilever, the country’s largest consumer products company, is unlikely to become the largest food company despite its acquisition of GSK Consumer business including Horlicks, because it still…
Maha FDA Yet To Set Up NPPA Cell To Detect Ceiling Price Violation
The Maharashtra Food and Drug Administration (FDA) is yet to set up an NPPA cell to deal with the drug price ceiling violation at its headquarters in Mumbai for want…
USFDA recommends regulatory action after Jubilant Life’s Roorkee plant inspection
New Delhi: The US health regulator has recommended a regulatory or administrative action after the inspection of Roorkee manufacturing facility of drug firm Jubilant Life Sciences, according to a regulatory…
AstraZeneca’s Imfinzi fails to meet main goals in head and neck cancer study
AstraZeneca Plc’s immunotherapy treatment Imfinzi did not meet the main goals in a late-stage study for advanced head and neck cancer, the London-listed drugmaker said on Friday. The study, known…
Moderna, largest biotech to go public, fails to impress in market debut
Moderna Inc’s shares fell as much as 6 percent in an upsized market debut on Friday, taking a hit from a broader selloff in the U.S. markets spurred by investors…
VAT scam: Pharmaceutical firm vice-chairman in judicial custody
CHANDIGARH: The district court remanded N R Munjal, vice-chairman, Ind-Swift pharma firm, to 14-day judicial custody. Munjal was arrested for his alleged involvement in the VAT evasion scam that rocked…
AstraZeneca Pharma inks distribution pact with Abbott for diabetes drug
New Delhi: Drug firm AstraZeneca Pharma India Friday said it has entered into a distribution agreement with Abbott Healthcare for distribution of diabetes medicine Dapagliflozin in India. Dapagliflozin, an innovative…
Bugworks Research set for pre-clinical drug trials
BENGALURU: Bugworks Research, a Bengaluru-based drug discovery startup, has moved a few steps closer to its goal of developing next-generation antibiotics. Its drug candidate is set to enter pre-clinical trials…
Moderna to raise $618 mln in upsized IPO, braving market jitters
By Lance Tupper and Joshua Franklin Moderna Inc is set to sell around $618 million in shares in its initial public offering (IPO) on Thursday, a person familiar with the…
Drug company Actelion to pay $360M in kickback probe
BOSTON: A pharmaceutical company has agreed to pay $360 million to resolve allegations that it used a charitable foundation to pay kickbacks to Medicare patients. The U.S. attorney’s office in…
